NCT06869915 Homelessness and Prevalence of Neurodevelopmental Disorders
| NCT ID | NCT06869915 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hôpital le Vinatier |
| Condition | Neurodevelopmental Disorders |
| Study Type | INTERVENTIONAL |
| Enrollment | 150 participants |
| Start Date | 2026-03-09 |
| Primary Completion | 2027-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 150 participants in total. It began in 2026-03-09 with a primary completion date of 2027-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Introduction \& Central question: Psychiatric disorders are highly prevalent in the homeless population, however neurodevelopmental disorders are also at risk of leading to homelessness (Churchard et al., 2018; Casey et al., 2020). Research on this topic is poor in France. This research aims to study the prevalence in France of 3 neurodevelopmental disorders (NDDs) in a homeless population (Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder and Intellectual Developmental Disorder). Methods / approach: A 2 phase approach will be used including a screening phase and a diagnosis phase. This research is a pilot study that will include 150 homeless people, over 2 years. The assessment involves combining the results from standardised self-report tools, direct observation and informant-report, thus guaranteeing an objective and thorough diagnosis. This approach gives a better picture of actual behaviour but also a better understanding of the person's development. OUTCOME: This study will give insight on how to better understand the profile of the homeless population in France, and the prevalence of autism in this population. It will also bring valuable knowledge on how autism and other NDDs can impact one's path in life and lead to homelessness. The results can help develop targeted cares and measures for homeless people with NDDs.
Eligibility Criteria
Inclusion Criteria: * Homeless people sheltered in accommodation and social rehabilitation centers * Over 18 years of age * Who speak French * who have given then written informed consent Exclusion Criteria: \- Every person who hasn't given their written informed consent.
Contact & Investigator
Caroline DEMILY, MdPh
PRINCIPAL INVESTIGATOR
VINATIER HOSPITAL
Frequently Asked Questions
Who can join the NCT06869915 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 90 Years, studying Neurodevelopmental Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06869915 currently recruiting?
Yes, NCT06869915 is actively recruiting participants. Contact the research team at gabrielle.chesnoy@ch-le-vinatier.fr for enrollment information.
Where is the NCT06869915 trial being conducted?
This trial is being conducted at Lyon, France.
Who is sponsoring the NCT06869915 clinical trial?
NCT06869915 is sponsored by Hôpital le Vinatier. The principal investigator is Caroline DEMILY, MdPh at VINATIER HOSPITAL. The trial plans to enroll 150 participants.